Literature DB >> 17678737

Endocannabinoid inhibition: a new cardioprotective strategy against doxorubicin cardiotoxicity.

Giovanni Fajardo, Daniel Bernstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17678737     DOI： 10.1016/j.jacc.2007.04.052

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.

Authors:  Giovanni Fajardo; Mingming Zhao; Gerald Berry; Lee-Jun Wong; Daria Mochly-Rosen; Daniel Bernstein
Journal:  J Mol Cell Cardiol       Date:  2011-07-02       Impact factor: 5.000

Review 2.  Endocannabinoids and the heart.

Authors:  C Robin Hiley
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

3.  Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes.

Authors:  Tiam Feridooni; Adam Hotchkiss; Sarah Remley-Carr; Yumiko Saga; Kishore B S Pasumarthi
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.